YRC Worldwide, Inc. (YRCW), Sarepta Therapeutics Inc (SRPT), Christopher & Banks Corporation (CBK): Russell Rebalance Could Push These Stocks Even Higher!

Page 1 of 2

Last year, these three stocks weren’t even on the radar of most retail investors, but have since returned incredible gains. Now, another catalyst could catapult each even higher, along with continued fundamental improvements.

What Are The Russell Indexes?

The Russell Indexes combined are tracked by more than $4 trillion, meaning that institutional and retail investors alike invest in their indexes more so than all other U.S. equity indexes combined. Among its offerings, are the Russell 2000, 3000, and Global indexes, which are among the most popular.

On Friday, Russell indexes began the process of rebalancing, which means purchasing new stocks and selling others. Those that are sold, no longer qualify, either falling below the requirements or being above the requirements.

Those that are purchased are typically IPOs or stocks that now meet certain requirements, while they may not have in the year prior. In this piece, I am looking at three such stocks; they are stocks that could move considerably higher with the rebalancing of Russell indexes.

YRC Worldwide, Inc. (NASDAQ:YRCW)

From Bankruptcy To Large Gains

Last year, YRC Worldwide, Inc. (NASDAQ:YRCW) was a $50 million company, today it is valued at $265 million. Its large gains have come after the company posted its first quarter of operating profit in many years’ time.

Moreover, the company is in talks to acquire a fellow trucking company, Arkansas Best, a company growing at more than 15% annually with over $2 billion in annual revenue. Currently, YRC Worldwide, Inc. (NASDAQ:YRCW) trades at 0.05 times sales, which is by far the cheapest in the transportation sector.

If the company can continue to improve then large gains can be created. On Friday, gains of almost 2% occurred due to it being added to the Russell funds. Thus, I’d watch this stock over the next week, as it trades near 52-week highs.

Unprecedented Data & Large Sales Potential Have Pushed This Stock Higher

Sarepta Therapeutics Inc (NASDAQ:SRPT) did not qualify for Russell funds last year, trading with a market cap of just $100 million. However, on Friday, it was added to both the Global and 3000 Russell indexes with a market cap of $1.2 billion.

Sarepta Therapeutics Inc (NASDAQ:SRPT)’ large gains were created after data for its Phase 2 Orphan candidate Eteplirsen for the treatment of Duchenne Muscular Dystrophy. Currently, there are no approved products for this disease, and analysts project that it could result in revenue of $700 million annually.

The company is awaiting an FDA decision on whether or not Eteplirsen’s approval can be accelerated. Sarepta Therapeutics Inc (NASDAQ:SRPT) continues to trade higher, as continuous checks on data from the Phase 2 trial indicate a drug that improves the outcome of the disease with time. With its institutional ownership on the rise, over the last year, I’d watch this stock, as the Russell inclusion could push shares even higher.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Best-Selling Cars in 2014

The 10 Best Industries to Invest In

The 10 Most Expensive States to Own a Car In

Top 10 Business Schools in US: 2014 Rankings

Top 20 Female Billionaires in 2014

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!